Mantle Cell Lymphoma

• FDA approval · 2008-06-20
  FDA Approved: VELCADE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for Velcade (bortezomib) submitted by Takeda Pharmaceuticals America, Inc.

• FDA approval · 2006-05-31
  FDA Approved: VELCADE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  FDA approved a supplemental application for Velcade (bortezomib) submitted by Takeda Pharmaceuticals America, Inc.